UBS Maintains Neutral on ArcBest, Lowers Price Target to $146
Benzinga Newsdesk 22 hours ago
Analyst RatingsNewsPrice Target
UBS analyst Thomas Wadewitz maintains ArcBest (NASDAQ:ARCB) with a Neutral and lowers the price target from $154 to $146.
UBS analyst Thomas Wadewitz maintains ArcBest (NASDAQ:ARCB) with a Neutral and lowers the price target from $154 to $146.